The data also highlighted the role of C5 activation in the formation of thrombotic microangiopathy (TMA) in the kidney and provided a model system that allows analysis of aspects of C3G and aHUS, a phenotype that can be seen in the clinic.99 The gene discussed is C5; the disease is Genetic thrombotic microangiopathy.